CVS Health Corporation (NYSE:CVS) Shares Sold by St. Johns Investment Management Company LLC

St. Johns Investment Management Company LLC trimmed its holdings in CVS Health Corporation (NYSE:CVS) by 26.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,400 shares of the pharmacy operator’s stock after selling 3,330 shares during the period. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $637,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. LaFleur & Godfrey LLC raised its stake in CVS Health by 49.9% during the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator’s stock worth $217,000 after purchasing an additional 1,610 shares during the period. TCW Group Inc. increased its holdings in shares of CVS Health by 2.5% during the 4th quarter. TCW Group Inc. now owns 17,601 shares of the pharmacy operator’s stock worth $790,000 after buying an additional 435 shares during the last quarter. Wealthspire Advisors LLC raised its position in shares of CVS Health by 10.1% in the 4th quarter. Wealthspire Advisors LLC now owns 15,962 shares of the pharmacy operator’s stock worth $717,000 after buying an additional 1,468 shares during the period. Howard Capital Management Inc. boosted its holdings in CVS Health by 13.6% in the fourth quarter. Howard Capital Management Inc. now owns 13,846 shares of the pharmacy operator’s stock valued at $622,000 after acquiring an additional 1,653 shares during the last quarter. Finally, B&D White Capital Company LLC purchased a new stake in CVS Health during the fourth quarter valued at about $417,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $66.93 on Tuesday. The company has a 50-day moving average price of $64.88 and a two-hundred day moving average price of $60.53. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The stock has a market cap of $84.67 billion, a price-to-earnings ratio of 15.97, a price-to-earnings-growth ratio of 0.95 and a beta of 0.56. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.31 EPS. Analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on CVS. Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Wells Fargo & Company restated an “overweight” rating and issued a $84.00 price target (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Morgan Stanley reiterated an “overweight” rating on shares of CVS Health in a research note on Tuesday, April 15th. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an “overweight” rating in a research report on Monday, June 2nd. Finally, UBS Group lifted their target price on shares of CVS Health from $67.00 to $71.00 and gave the company a “neutral” rating in a report on Friday, May 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $74.75.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone purchased 1,570 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.